Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis First Trust NYSE Arca Biotechnology Index Fund FBT

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted... see more

Opinion & Analysis (ARCA:FBT)

    Major funds betting on Trump sector

    The Life Sciences Report February 28, 2017

    Investing in life sciences under the Trump presidency

    The Life Sciences Report February 17, 2017

    Regeneus hits the fast track with major Japanese partnership

    The Life Sciences Report February 9, 2017

    Can biotech's Trump bump last?

    The Life Sciences Report December 5, 2016

    Regeneus secures government funding for R&D

    The Life Sciences Report September 14, 2016

    A Wild Day For A Beloved Momentum ETF

    Benzinga.com  August 24, 2015

    Even With Recent Declines, Investors Still Love Biotech ETFs

    Benzinga.com  July 30, 2015

    These 2 Hated ETFs Have Outperformed The Market

    Benzinga.com  March 31, 2015

    Biotech Stocks Sell Off, ETFs Fall Over 5%

    Benzinga.com  December 23, 2014

    2 New Biotech ETFs Offer Unique Industry Focus

    Benzinga.com  December 18, 2014

    3 Biotech ETFs Rally On Merger News

    Benzinga.com  December 8, 2014

    Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

    Benzinga.com  August 27, 2014

    'Pure-play' ETFs might be a shrewd investment

    Larry D. Spears May 19, 2010

    Biotechnology headed for a downturn?

    Nick Thomas November 9, 2009